Royal Gold Inc (0KXS)
London Exchange · UK · prices in USD · close of 22 Oct 2026
Key indicators
| Last close | USD 232.98 |
|---|---|
| 52-week range | 169.10 – 312.15 |
| Return, 1 month / 3 months | −9.0% / +17.0% |
| Return, 1 year / 3 years | +29.0% / +117.7% |
| Trend | Below its 200-day average |
| RSI (14) | 44 |
| Volatility (1 year) | 39.9% |
| Worst drawdown (1 year) | -37.1% |
| Average daily value traded | 0.42M USD |
| Dividend yield | 0.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Royal Gold is a precious metals royalty and streaming company based in Denver, Colorado. Rather than operating mines itself, it acquires royalty interests and streaming agreements that give it the right to a portion of the metal produced or revenue earned from mines run by other companies. Its portfolio spans producing and development-stage gold, silver and copper properties in several countries, and its customers are the mining companies that operate those assets.
The shares are listed on the London Exchange in UK under the code 0KXS, and the price on this page is in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Royal Gold Inc (0KXS) trades on the London Exchange in UK. It last closed at USD 232.98 on 22 October 2026.
Its price-based Market X-Ray is 47 out of 100 (a weak price profile), ranking 2,214 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 29.0% and over the last three months it rose 17.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 46 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -3.1% | ||
| From 52-week high | -22.6% | ||
| Momentum | 68 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 17.0% | ||
| 6-month return | -7.1% | ||
| 12-month return, skipping the last month | 41.9% | ||
| Stability (higher is calmer) | 38 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 39.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -37.1% | ||
| Liquidity | 44 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.42M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 27 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.8% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.6% |
|---|---|
| 1 month | −9.0% |
| 3 months | +17.0% |
| 6 months | −7.1% |
| 1 year | +29.0% |
| 3 years | +117.7% |
| 5 years | – |
Signals
| 50-day / 200-day average | 245.57 / 240.38 |
|---|---|
| Golden / death cross (60 days) | Golden, 12 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 9.75 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 1 Oct 2026 | USD 0.4750 |
| 1 Jul 2026 | USD 0.4750 |
| 1 Apr 2026 | USD 0.4750 |
| 31 Dec 2025 | USD 0.4750 |
| 2 Oct 2025 | USD 0.4500 |
| 2 Jul 2025 | USD 0.4500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.